14 Wiryeseong-daero
Songpa-gu
Seoul 05545
South Korea
82 2 410 9114
https://www.hanmiscience.co.kr
Sector(s): Healthcare
Industry: Medical Distribution
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Sung-Ki Lim | Founder & Chairman | N/A | N/A | 1940 |
Mr. Lim Chong-Yoon | Chief Executive Officer, President and Director | N/A | N/A | 1972 |
Mr. Jong-Soo Woo Ph.D. | President & Director | N/A | N/A | 1967 |
Mr. Se-Chang Gwon | President & Director | N/A | N/A | 1963 |
Mr. Chan Seob Kim | CFO & Senior MD | N/A | N/A | 1965 |
Mr. Jong-Ho Lim | Managing Director of Administration, Purchasing & Management | N/A | N/A | 1961 |
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.
Hanmi Science Co., Ltd.’s ISS Governance QualityScore as of May 1, 2024 is 8. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 8; Compensation: 7.